Ethics approval and consent to participate
RFID trial has been approved by ethics committee (Ile de France XI) (ID-RCB number: 2021-A00281-40). Patients who agree to participate in this study will provide oral consent for enrolment and the investigator will sign a document demonstrating that the patient has been informed and has agreed to participate.